Add BrightSurf on Google Email

Society for the Study of Addiction


The stop-smoking medication varenicline may also work for cannabis use disorder

A new study found that varenicline, a medication used to quit smoking, can help men with cannabis use disorder reduce their cannabis use. However, the same treatment showed no significant effect on female participants. Women who received varenicline reported higher withdrawal and craving scores and lower medication adherence compared t...

SourceSociety for the Study of Addiction·JournalAddiction·TypeRandomized controlled/clinical trial·DateJan 15, 2026

New study shows young adults who use high strength cannabis do not ‘titrate’ to less risky levels of use

A new study found that young adults using high-strength cannabis in California tend to consume more and experience greater symptoms of cannabis use disorder. The study, which surveyed over 400 participants, showed a significant association between THC potency and cannabis consumption frequency and quantity.

SourceSociety for the Study of Addiction·JournalAddiction·TypeSurvey·DateJul 31, 2025

Ozempic (and similar medications) may be the new treatment for opioid and alcohol use disorder

A new study found that people with opioid or alcohol use disorder who take Ozempic or similar medications have a lower rate of opioid overdose and alcohol intoxication. The medication, which treats diabetes and weight-related conditions, may also alter the brain's reward-response pathways associated with substance use.

SourceSociety for the Study of Addiction·JournalAddiction·TypeObservational study·DateOct 17, 2024

Three top ways to stop smoking

A major new review of evidence has identified three top ways to stop smoking: combining behaviour support with medication like bupropion or nicotine replacement therapy. The Cochrane Tobacco Addiction Group's systematic reviews also found strong evidence for behavioural counselling and financial incentives.

SourceSociety for the Study of Addiction·JournalAddiction·TypeSystematic review·DateSep 4, 2024

Trained peers are as effective as clinical social workers in reducing opioid overdose, new trial finds

A randomized controlled trial found that support from a peer recovery support specialist was as effective in reducing opioid overdose as support from a licensed clinical social worker. The trial included 648 ED patients at high risk of opioid overdose and showed no significant difference between the two groups in fatal opioid overdoses.

SourceSociety for the Study of Addiction·JournalAddiction·TypeRandomized controlled/clinical trial·DateJul 11, 2024

Black people who fatally overdose in Pennsylvania are half as likely to receive naloxone as white people

A new study of 11,000 overdose deaths in Pennsylvania found that Black people who died from an overdose were half as likely to have received naloxone as white people. This racial disparity in naloxone administration highlights the need for targeted strategies to distribute life-saving medication and educate communities about its use.

SourceSociety for the Study of Addiction·JournalAddiction·TypeData/statistical analysis·DateMay 29, 2024

Treating amphetamine use disorder with stimulants: an encouraging new approach

A new meta-analysis suggests that high-dose prescription psychostimulants like methylphenidate and dextroamphetamine can lower cravings and reduce stimulant use in people with amphetamine-type stimulant use disorder. The study analyzed ten randomized controlled trials and found that effects may increase with higher dosage.

SourceSociety for the Study of Addiction·JournalAddiction·TypeMeta-analysis·DateOct 26, 2023

Cannabis use disorder may be linked to increased risk of cardiovascular disease

A new study has found a significant association between cannabis use disorder and an increased risk of cardiovascular disease events such as heart attacks and strokes. Adults with cannabis use disorder in Canada experienced a 60% higher risk of first-time cardiovascular disease events compared to those without the disorder.

SourceSociety for the Study of Addiction·JournalAddiction·TypeObservational study·DateSep 28, 2023

New review finds the benefits of a widely-used treatment for gambling problems may be overstated

A new meta-analysis of 29 randomized controlled trials on cognitive-behavioral techniques for treating gambling problems found mixed results, including potential overstatements of treatment benefits. The analysis highlighted publication bias and limited funding as contributing factors to the shortcomings of existing research.

SourceSociety for the Study of Addiction·JournalAddiction·TypeMeta-analysis·DateJun 29, 2023

Leading addiction researchers denounce Australia’s NHMRC statement on e-cigarettes

Leading addiction scientists criticize Australia's National Health and Medical Research Council (NHMRC) for its 2022 statement on e-cigarettes, which they say selectively cites evidence and relies on flawed analysis. The critique argues that the NHMRC statement confuses association with causation and adopts a double standard.

SourceSociety for the Study of Addiction·JournalAddiction·TypeCommentary/editorial·DateFeb 20, 2023

When alcohol becomes cheaper, abortions and adverse birth outcomes increase, new research shows

A Finnish study found that lowering alcohol prices led to a short-term increase in abortions and adverse birth outcomes, particularly among low-income women. Both factors returned to normal levels after several months. The research suggests that cheaper alcohol may lead to increased drinking and prenatal exposure to alcohol.

SourceSociety for the Study of Addiction·JournalAddiction·TypeObservational study·DateFeb 15, 2023

Legalizing recreational cannabis in the U.S. has increased frequency of use by 20%

A new study published in the journal Addiction found that recreational cannabis legalization in US states led to a 20% increase in cannabis use frequency, particularly among identical twin pairs. The study analyzed data from over 1,400 individuals and suggested that recreational legalization caused an increase in cannabis use.

SourceSociety for the Study of Addiction·JournalAddiction·TypeObservational study·DateAug 25, 2022